SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver first-in-class transformative therapies for patients facing life-changing disease, today ...

"I wanted to create a convenient way to charge and store up to four power tool batteries at the same time," said an inventor, from Lafayette¸ Ind., "so I invented the PROJECT SAVER. My design ensures ...

This endeavour seeks to offer a more nuanced, responsible, and humane approach to shaping our built environments ...

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission ...

Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...

Putting the pieces of the puzzle together for yourself is very rewarding. As show by these 10 Best Games That Don't ...

Related: The Massive Flea Market in Oregon Where You’ll Find Rare Treasures at Rock-Bottom Prices Some of St. Vinnie’s most ...

While the decision to have a poster presentation at 2025 ASCO® was based on the limited data included in the submitted abstract ... of our proprietary technology; our patents may be found ...

While the decision to have a poster presentation at 2025 ASCO® was based on the limited data included in the submitted abstract, we are very much looking ... protection of our proprietary technology; ...

Lipella Pharmaceuticals (LIPO) announced that its abstract on LP-10 for the treatment of Oral Lichen Planus, OLP, has been accepted for podium presentation at the 2025 joint international meeting ...